Long-Term Outcome of Oxaliplatin and Capecitabine (XELOX) Concomitant with Neoadjuvant Radiotherapy and Extended to the Resting Period in High Risk Locally Advanced Rectal Cancer.

Whether receiving adjuvant chemotherapy or not was the only significant predictor for DFS, with hazard ratio 0.24 (95% CI: 0.08-0.74), and a positive trend was observed for primary tumor downstaging 0.50 (95% CI: 0.19-1.58) (Table 2 ).

also in 11,005 other papers